• 2022
  Martin A, Woolbright BL, Umar S, Ingersoll MA & Taylor III JA, Bladder cancer, inflammaging and microbiomes, Nat. Rev. Urol. 2022.
• 2021
  Luzuriaga MA, Herbert FC, Brohlin OR, Gadhvi J, Howlett T, Shahrivarkevishahi A, Wijesundara YH, Venkitapathi S, Veera K, Ehrman R, Benjamin CE, Popal S, Burton MD, Ingersoll MA, De Nisco NJ, Gassensmith JJ, , Metal-Organic Framework Encapsulated Whole-Cell Vaccines Enhance Humoral Immunity against Bacterial Infection., ACS Nano 2021 Sep; (): .
• 2021
  Lupo F, Ingersoll MA, Pineda MA, , The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity., Immunology 2021 Mar; (): .
• 2020
  Lupo F, Rousseau M, Canton T, Ingersoll MA, , The Immune System Fails to Mount a Protective Response to Gram-Positive or Gram-Negative Bacterial Prostatitis., J Immunol 2020 11; 205(10): 2763-2777.
• 2020
  Lacerda Mariano L, Rousseau M, Varet H, Legendre R, Gentek R, Saenz Coronilla J, Bajenoff M, Gomez Perdiguero E, Ingersoll MA, , Functionally distinct resident macrophage subsets differentially shape responses to infection in the bladder., Sci Adv 2020 Nov; 6(48): .
• 2020
  Rousseau M, O'Brien CJO, Antequera E, Zdimerova H, Cansever D, Canton T, Zychlinsky Scharff A & Ingersoll MA, Identification of sex differences in tumor-specific T cell infiltration in bladder tumor-bearing mice treated with BCG immunotherapy, Bladder Cancer, 2020 Oct.
• 2020
  Lacerda Mariano L, Ingersoll MA, , The immune response to infection in the bladder., Nat Rev Urol 2020 Jul; (): .
• 2020
  Lacerda Mariano L, Ingersoll MA, The road to recovery – the immune response to infection in the bladder, Nat. Rev. Urol. 2020.
• 2020
  Ingersoll MA, Starkey MR, , Interleukin-22 in urinary tract disease – new experimental directions., Clin Transl Immunology 2020 ; 9(6): e1143.
• 2019
  Zychlinsky Scharff A, Rousseau M, Lacerda Mariano L, Canton T, Consiglio CR, Albert ML, Fontes M, Duffy D, Ingersoll MA, Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection, JCI Insight 2019 July;4(13):e122998.
• 2019
  Song D, Powles T, Shi L, Zhang L, Ingersoll MA, Lu YJ, Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches, J Pathol. 2019 Oct;249(2):151-165..
• 2019
  Lupo F, Ingersoll MA, Is bacterial prostatitis a urinary tract infection?, Nat Rev Urol 2019 Apr;16(4):203-204.
• 2019
  Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S, Pal SK, Sfanos KS, The Microbiome and Genitourinary Cancer: A Collaborative Review, Eur. Urol. 2019 04;75(4):637-646.
• 2019
  Perot BP, Boussier J, Ingersoll MA, [Macroautophagy limits the early induction of interferon-β during influenza A virus infection], Med Sci (Paris) 2018 12;34(12):1035-1038.
• 2018
  Rentsch CA, Derré L, Dugas SG, Wetterauer C, Federer-Gsponer JR, Thalmann GN, Ingersoll MA, Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy, Eur Urol Focus 2018 07;4(4):485-493.
• 2018
  Dyrskjøt L, Ingersoll MA, Biology of nonmuscle-invasive bladder cancer: pathology, genomic implications, and immunology, Curr Opin Urol 2018 11;28(6):598-603.
• 2018
  Ingersoll MA, Li X, Inman BA, Greiner JW, Black PC, Adam RM, Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer, Bladder Cancer 2018 Oct;4(4):429-440.
• 2018
  Pettenati C, Ingersoll MA, Mechanisms of BCG immunotherapy and its outlook for bladder cancer, Nat Rev Urol 2018 Oct;15(10):615-625.
• 2018
  Casrouge A, Sauer AV, Barreira da Silva R, Tejera-Alhambra M, Sánchez-Ramón S, ICAReB , Cancrini C, Ingersoll MA, Aiuti A, Albert ML, Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4, Clin. Exp. Immunol. 2018 Nov;194(2):166-179.
• 2018
  Williams JW, Martel C, Potteaux S, Esaulova E, Ingersoll MA, Elvington A, Saunders BT, Huang LH, Habenicht AJ, Zinselmeyer BH, Randolph GJ, Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report, Arterioscler. Thromb. Vasc. Biol. 2018 Aug;38(8):1702-1710.
• 2018
  Perot BP, Boussier J, Yatim N, Rossman JS, Ingersoll MA, Albert ML, Autophagy diminishes the early interferon-β response to influenza A virus resulting in differential expression of interferon-stimulated genes, Cell Death Dis 2018 05;9(5):539.
• 2018
  Lacerda Mariano L, Ingersoll MA, Bladder resident macrophages: Mucosal sentinels, Cell. Immunol. 2018 08;330:136-141.
• 2018
  O'Brien CJO., Rousseau M. & Ingersoll MA, Present and future immunotherapy for bladder cancer, Bladder Cancer : International Consultation on Urological Diseases.
• 2017
  Ingersoll MA, Sex differences shape the response to infectious diseases, PLoS Pathog. 2017 12;13(12):e1006688.
• 2017
  Zychlinsky Scharff A, Albert ML, Ingersoll MA, Urinary Tract Infection in a Small Animal Model: Transurethral Catheterization of Male and Female Mice, J Vis Exp 2017 12;(130).
• 2017
  Tien BYQ, Goh HMS, Chong KKL, Bhaduri-Tagore S, Holec S, Dress R, Ginhoux F, Ingersoll MA, Williams RBH, Kline KA, Enterococcus faecalis Promotes Innate Immune Suppression and Polymicrobial Catheter-Associated Urinary Tract Infection, Infect. Immun. 2017 12;85(12).
• 2017
  Kamat AM, Li R, O'Donnell MA, Black PC, Roupret M, Catto JW, Comperat E, Ingersoll MA, Witjes WP, McConkey DJ, Witjes JA, Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review, Eur. Urol. 2018 05;73(5):738-748.
• 2017
  Flaig TW, Kamat AM, Hansel D, Ingersoll MA, Barton Grossman H, Mendelsohn C, DeGraff D, Liao JC, Taylor JA, Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium, Bladder Cancer 2017 Jul;3(3):211-223.
• 2017
  da Silva RB, Ingersoll MA, Albert ML, , Measurement of Dipeptidylpeptidase Activity in vitro and in vivo., Bio Protoc 2017 Mar; 7(6): e2184.
• 2016
  Grossman HB, Lamm DL, Kamat AM, Keefe S, Taylor JA, Ingersoll MA, Innovation in Bladder Cancer Immunotherapy, J. Immunother. 2016 10;39(8):291-7.
• 2016
  Rousseau M, Goh HMS, Holec S, Albert ML, Williams RB, Ingersoll MA, Kline KA, Bladder catheterization increases susceptibility to infection that can be prevented by prophylactic antibiotic treatment, JCI Insight 2016 09;1(15):e88178.
• 2015
  Cui Y, Franciszkiewicz K, Mburu YK, Mondot S, Le Bourhis L, Premel V, Martin E, Kachaner A, Duban L, Ingersoll MA, Rabot S, Jaubert J, De Villartay JP, Soudais C, Lantz O, Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation, J. Clin. Invest. 2015 Nov;125(11):4171-85.
• 2015
  Mora-Bau G, Platt AM, van Rooijen N, Randolph GJ, Albert ML, Ingersoll MA, Macrophages Subvert Adaptive Immunity to Urinary Tract Infection, PLoS Pathog. 2015 Jul;11(7):e1005044.
• 2015
  Barreira da Silva R, Laird ME, Yatim N, Fiette L, Ingersoll MA, Albert ML, Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy, Nat. Immunol. 2015 Aug;16(8):850-8.
• 2014
  Kamat AM, Vlahou A, Taylor JA, Hudson ML, Pesch B, Ingersoll MA, Todenhöfer T, van Rhijn B, Kassouf W, Barton Grossman H, Behrens T, Chandra A, Goebell PJ, Palou J, Sanchez-Carbayo M, Schmitz-Dräger BJ, Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer, Urol. Oncol. 2014 Oct;32(7):1069-77.
• 2014
  Rentsch CA, Birkhäuser FD, Biot C, Gsponer JR, Bisiaux A, Wetterauer C, Lagranderie M, Marchal G, Orgeur M, Bouchier C, Bachmann A, Ingersoll MA, Brosch R, Albert ML, Thalmann GN, Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy, Eur. Urol. 2014 Oct;66(4):677-88.
• 2014
  Schmitz-Dräger BJ, Todenhöfer T, van Rhijn B, Pesch B, Hudson MA, Chandra A, Ingersoll MA, Kassouf W, Palou J, Taylor J, Vlahou A, Behrens T, Critelli R, Grossman HB, Sanchez-Carbayo M, Kamat A, Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer, Urol. Oncol. 2014 Oct;32(7):1061-8.
• 2013
  Ingersoll MA, Albert ML, From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa, Mucosal Immunol 2013 Nov;6(6):1041-53.
• 2013
  Perot BP, Ingersoll MA, Albert ML, The impact of macroautophagy on CD8(+) T-cell-mediated antiviral immunity, Immunol. Rev. 2013 Sep;255(1):40-56.
• 2011
  Ingersoll MA, Platt AM, Potteaux S, Randolph GJ, Monocyte trafficking in acute and chronic inflammation, Trends Immunol. 2011 Oct;32(10):470-7.
• 2011
  Ingersoll MA, Potteaux S, Alvarez D, Hutchison SB, van Rooijen N, Randolph GJ, Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis, Immunobiology 2012 May;217(5):548-57.
• 2010
  Kline KA, Ingersoll MA, Nielsen HV, Sakinc T, Henriques-Normark B, Gatermann S, Caparon MG, Hultgren SJ, Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence, Infect. Immun. 2010 May;78(5):1943-51.
• 2009
  Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, Lang R, Haniffa M, Collin M, Tacke F, Habenicht AJ, Ziegler-Heitbrock L, Randolph GJ, Comparison of gene expression profiles between human and mouse monocyte subsets, Blood 2010 Jan;115(3):e10-9.
• 2009
  Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, Liu K, Jakubzick C, Ingersoll MA, Leboeuf M, Stanley ER, Nussenzweig M, Lira SA, Randolph GJ, Merad M, Origin of the lamina propria dendritic cell network, Immunity 2009 Sep;31(3):513-25.
• 2008
  Ingersoll MA, Kline KA, Nielsen HV, Hultgren SJ, G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity, Cell. Microbiol. 2008 Dec;10(12):2568-78.
• 2006
  Ingersoll MA, Zychlinsky A, ShiA abrogates the innate T-cell response to Shigella flexneri infection, Infect. Immun. 2006 Apr;74(4):2317-27.
• 2003
  Ingersoll MA, Moss JE, Weinrauch Y, Fisher PE, Groisman EA, Zychlinsky A, The ShiA protein encoded by the Shigella flexneri SHI-2 pathogenicity island attenuates inflammation, Cell. Microbiol. 2003 Nov;5(11):797-807.
• 2002
  Ingersoll M, Groisman EA, Zychlinsky A, Pathogenicity islands of Shigella, Curr. Top. Microbiol. Immunol. 2002;264(1):49-65.